HOLX [NASD]
Hologic, Inc.
IndexS&P 500 P/E11.49 EPS (ttm)6.07 Insider Own0.20% Shs Outstand251.57M Perf Week2.32%
Market Cap17.31B Forward P/E19.06 EPS next Y3.66 Insider Trans-3.80% Shs Float247.60M Perf Month-8.41%
Income1.55B PEG6.76 EPS next Q0.70 Inst Own98.18% Short Float3.29% Perf Quarter-8.18%
Sales5.39B P/S3.21 EPS this Y71.00% Inst Trans1.17% Short Ratio3.90 Perf Half Y-9.20%
Book/sh19.05 P/B3.66 EPS next Y-34.15% ROA17.10% Target Price79.50 Perf Year3.42%
Cash/sh9.24 P/C7.56 EPS next 5Y1.70% ROE35.70% 52W Range65.75 - 81.04 Perf YTD-8.86%
Dividend- P/FCF6.44 EPS past 5Y44.20% ROI27.10% 52W High-13.89% Beta1.08
Dividend %- Quick Ratio2.60 Sales past 5Y14.70% Gross Margin64.20% 52W Low6.13% ATR1.77
Employees6705 Current Ratio3.00 Sales Q/Q-6.60% Oper. Margin37.70% RSI (14)42.37 Volatility2.25% 2.25%
OptionableYes Debt/Eq0.65 EPS Q/Q-24.40% Profit Margin28.80% Rel Volume0.61 Prev Close71.46
ShortableYes LT Debt/Eq0.59 EarningsJun 07 BMO Payout0.00% Avg Volume2.09M Price69.78
Recom2.10 SMA20-3.11% SMA50-5.57% SMA200-5.08% Volume1,279,777 Change-2.35%
Apr-25-22Downgrade Wells Fargo Overweight → Equal Weight $75
Apr-04-22Downgrade Evercore ISI Outperform → In-line $80
Dec-15-21Downgrade Citigroup Buy → Neutral $85 → $78
Oct-15-21Resumed Cowen Outperform $83
Oct-14-21Initiated Redburn Neutral
Jul-06-21Upgrade Evercore ISI In-line → Outperform $78
Nov-20-20Downgrade Needham Buy → Hold
Nov-05-20Reiterated Needham Buy $78 → $88
Jun-30-20Upgrade Cowen Market Perform → Outperform $64
Jun-03-20Upgrade Raymond James Mkt Perform → Outperform $62
Apr-30-20Upgrade SVB Leerink Mkt Perform → Outperform $62
Apr-30-20Reiterated Needham Buy $52 → $60
Apr-07-20Upgrade Wells Fargo Equal Weight → Overweight $48
Mar-27-20Upgrade Morgan Stanley Underweight → Equal-Weight $40
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $24
Jan-13-20Reiterated Needham Buy $57 → $62
Jan-08-20Initiated Wells Fargo Equal Weight $57
Jan-07-20Initiated Citigroup Buy $60
Jan-02-20Downgrade Evercore ISI Outperform → In-line
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $54 → $59
Jun-27-22 05:45PM  
Jun-23-22 09:00AM  
Jun-21-22 05:45PM  
Jun-17-22 09:34AM  
Jun-15-22 05:45PM  
03:28PM  
Jun-08-22 05:45PM  
11:30AM  
09:00AM  
Jun-02-22 05:45PM  
May-27-22 11:04AM  
10:08AM  
May-25-22 09:00AM  
08:02AM  
May-24-22 02:44PM  
May-23-22 02:41PM  
08:30AM  
May-18-22 12:53PM  
May-17-22 08:15AM  
May-11-22 09:00AM  
May-10-22 04:02PM  
May-09-22 02:07PM  
May-04-22 08:30AM  
Apr-28-22 11:41AM  
Apr-27-22 09:30PM  
05:15PM  
04:01PM  
Apr-26-22 10:09AM  
07:31AM  
Apr-25-22 09:46AM  
08:08AM  
Apr-22-22 09:00AM  
Apr-21-22 09:14AM  
Apr-20-22 03:02PM  
Apr-19-22 05:45PM  
Apr-14-22 09:35AM  
08:30AM  
Apr-13-22 12:10PM  
Apr-11-22 10:52AM  
09:03AM  
Apr-06-22 05:45PM  
04:21PM  
Apr-05-22 11:40AM  
Apr-04-22 04:01PM  
01:24PM  
Mar-31-22 05:25PM  
09:30AM  
Mar-30-22 05:45PM  
Mar-29-22 09:10AM  
Mar-24-22 05:45PM  
08:00AM  
Mar-21-22 07:30AM  
Mar-18-22 05:45PM  
Mar-17-22 09:35AM  
Mar-14-22 06:40AM  
Mar-13-22 12:59PM  
Mar-10-22 05:45PM  
12:48PM  
12:17PM  
05:41AM  
Mar-09-22 04:54PM  
08:00AM  
Mar-04-22 11:30AM  
Mar-03-22 05:45PM  
07:40AM  
07:00AM  
06:24AM  
06:11AM  
Feb-15-22 04:05PM  
Feb-14-22 08:44AM  
Feb-08-22 10:51AM  
Feb-03-22 11:05PM  
09:43AM  
08:33AM  
Feb-02-22 05:45PM  
04:01PM  
01:38PM  
Feb-01-22 09:38AM  
08:33AM  
07:00AM  
Jan-31-22 11:43AM  
09:30AM  
08:58AM  
08:19AM  
Jan-28-22 11:04AM  
10:38AM  
Jan-27-22 11:42AM  
10:50AM  
10:45AM  
08:33AM  
08:32AM  
08:32AM  
Jan-26-22 03:01PM  
10:47AM  
Jan-25-22 01:41PM  
10:59AM  
10:56AM  
10:41AM  
Jan-24-22 05:45PM  
08:08AM  
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHN BENJAMIN JORDANPrincipal Accounting OfficerMay 17Option Exercise40.853,844157,02717,376May 19 04:59 PM
Verstreken JanGroup President, InternationalMay 17Sale78.806,500512,16864,191May 19 05:01 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerMay 17Sale78.753,844302,73013,532May 19 04:59 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerMay 13Option Exercise39.397,052277,77017,374May 17 04:13 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerMay 13Sale75.497,052532,36513,532May 17 04:13 PM
Daugherty Sean S.Group President, BSH & Surg.Feb 24Sale71.142,179155,01649,091Feb 28 04:07 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerNov 19Sale75.792,570194,79115,604Nov 23 04:05 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 10Option Exercise37.645,000188,20021,896Aug 12 04:14 PM
COHN BENJAMIN JORDANPrincipal Accounting OfficerAug 10Sale77.485,000387,42516,896Aug 12 04:14 PM
Griffin John M.General CounselAug 09Option Exercise37.6426,6831,004,348150,283Aug 11 04:08 PM
Griffin John M.General CounselAug 09Sale75.6226,6832,017,768123,600Aug 11 04:08 PM